TOKYO —

Reducing calorie intake has long been a subject of intense scientific scrutiny, with studies across diverse animal models, including mice, rhesus monkeys, and fruit flies, consistently demonstrating a link between caloric restriction and extended lifespan. Beyond mere longevity, these investigations have frequently indicated that animals subjected to reduced calorie diets often exhibit improved health markers for longer periods. However, the pursuit of these benefits has been tempered by the significant downsides associated with severe calorie restriction. For instance, mice placed on diets with a 40% reduction in calories have been observed to become more susceptible to infections, experience diminished reproductive success, and display impaired growth, highlighting a critical trade-off.

This complex interplay between longevity and well-being has presented researchers with a persistent challenge: can humans reap the life-extending advantages of calorie restriction without enduring its detrimental physiological costs? A groundbreaking new study, published in the prestigious journal Nature Aging, offers a compelling potential answer, pointing to the crucial role of an immune protein known as complement component 3 (C3).

Unraveling the Mystery of Moderate Calorie Restriction

Building upon prior foundational research, scientists at Yale School of Medicine have previously demonstrated that individuals who engaged in moderate calorie restriction—specifically, a reduction of 14% in daily calorie intake sustained over two years—experienced a notable enhancement in their immune defenses. Crucially, these participants did not exhibit the adverse effects on growth or reproduction that have been observed in animal models undergoing more extreme dietary regimens.

"This concept fundamentally demonstrates that aging is not an immutable process but rather a malleable one, a biological phenomenon that can be actively targeted and influenced," stated senior author Vishwa Deep Dixit, PhD, Waldemar Von Zedtwitz Professor of Pathology, professor of immunobiology and of comparative medicine, and director of the Yale Center for Research on Aging (Y-Age) at Yale School of Medicine. His remarks underscore a paradigm shift in how aging is perceived—moving from an inevitable decline to a dynamic state with potential for intervention.

The CALERIE Study: A Deep Dive into Human Physiology

The new investigation delved into plasma samples from 42 participants in the National Institutes of Health-funded two-year study known as the Comprehensive Assessment of Long-Term Effects of Reducing Intake of Energy, or CALERIE. This meticulously controlled trial is recognized as one of the most rigorous and informative studies of its kind, offering significant insights into human physiology. During the CALERIE trial, participants voluntarily reduced their calorie intake by a moderate range of 11% to 14% without reporting feelings of deprivation, a key factor in the study’s success and adherence.

"It’s the only trial of its kind that has been done with such rigor and control and demonstrates relevance to human physiology," emphasized Dr. Dixit, underscoring the study’s unique contribution to the field.

C3: A Protein Linked to Inflammation and Aging

The Yale researchers embarked on an extensive analysis, measuring over 7,000 proteins within plasma samples collected from participants at various intervals throughout the two-year CALERIE study. Among this vast proteomic landscape, one protein emerged as particularly significant: complement component 3 (C3). The study observed a substantial decrease in the levels of this immune protein following the period of calorie restriction.

The heightened interest in C3 stems from earlier research suggesting a link between the activation of the complement system—a complex network of proteins essential for defending the body against pathogens—and the development of chronic inflammation. This persistent, low-grade inflammation is widely considered a hallmark of the aging process and a significant contributing factor to numerous age-associated diseases.

"But the causal effects of C3 in aging and chronic inflammation have not been identified. So, we were very excited to find that in our study," commented Hee-Hoon Kim, PhD, a postdoctoral associate in the Dixit lab and a co-first author of the paper. Her statement highlights the novelty and importance of their findings in establishing a direct link.

Adipose Tissue: The Unexpected Source of C3

A critical discovery of the study was the identification of white adipose tissue, the primary form of fat tissue in mammals, as a key tissue affected by the dietary intervention. By comparing protein levels before and after two years of calorie restriction, the team pinpointed adipose tissue as a significant site where C3 expression changed in response to the reduced calorie intake.

To validate these findings, the researchers replicated the experiment in animal models. Consistent with their observations in human plasma, C3 levels were found to increase with age in mice. Further biochemical analyses revealed that visceral white adipose tissue, the fat located around internal organs, was a major contributor to this age-related surge in C3.

"We were not expecting that because these proteins are mainly synthesized in the liver," remarked Manish Mishra, PhD, a postdoctoral associate in the Dixit lab and a co-first author of the study, expressing surprise at the unexpected role of adipose tissue.

Utilizing advanced single-cell RNA sequencing techniques, the researchers were able to further refine the source of C3 production. They identified that C3 was being actively produced by age-associated macrophages, a critical type of white blood cell residing within adipose tissue.

"This whole process was unknown in the beginning," Dr. Mishra explained. "Just to narrow it down to the subtypes of macrophages responsible for this complement protein production was very challenging." Macrophages, a vital component of the immune system, are primarily known for their role in engulfing and neutralizing pathogens. However, as Dr. Dixit added, they also play a crucial role in maintaining the normal functioning and homeostasis of tissues.

Decoupling Benefits from Weight Loss: A Paradigm Shift

The subsequent question that arose from these findings was whether the observed health benefits of calorie restriction could be achieved independently of significant weight loss. Initially, the researchers hypothesized that a reduction in adipose tissue mass itself might lead to decreased C3 production, thereby contributing to healthier aging. Indeed, the majority of participants in the CALERIE study experienced an average weight loss of approximately 18 pounds over the two-year period.

However, a detailed analysis comparing changes in body mass index (BMI) with alterations in complement protein levels revealed a striking absence of correlation. The amount of weight lost by participants did not appear to be directly linked to the decline in C3 levels.

"This suggests that calorie restriction has a beneficial effect that is unique to adipose tissues and is likely independent of weight loss," Dr. Kim concluded. This finding is particularly significant, as it opens the door to the possibility that some of the remarkable biological advantages associated with calorie restriction might be attainable without the necessity of substantial weight reduction, a factor that can be challenging for many individuals to achieve or maintain.

Therapeutic Implications: Targeting C3 to Combat Inflammation

To further investigate this hypothesis, the research team employed a pharmacological approach in mice. By using a drug to inhibit C3 activation, they effectively mimicked one of the key outcomes observed with calorie restriction. The results were compelling: the treated mice exhibited a significant reduction in age-related inflammation.

Dr. Dixit interpreted this finding as a powerful illustration of the principle of antagonistic pleiotropy, a concept first proposed by biologist Peter Medawar in 1952. This theory suggests that genes or biological mechanisms that confer an advantage early in life may become detrimental in later life. Growth hormone, for example, is essential for early development but has been implicated in contributing to cancer risk in older age.

Similarly, C3 and other proteins within the complement system evolved as vital defense mechanisms against infection. However, with the significant increase in human lifespan compared to our evolutionary ancestors, these same protective mechanisms may, over time, begin to contribute to the development of chronic diseases. Dr. Dixit posited that the strategic reduction of excessive C3 activity could potentially play a role in extending health span—the period of life spent in good health.

Future Directions: Repurposing Existing Drugs

The research team is now actively exploring the potential of existing FDA-approved inhibitor drugs to suppress C3 production. The ultimate goal is to determine if these drugs could be safely and effectively used to slow down certain aspects of aging in humans.

It is crucial to emphasize that the objective is not to eliminate the complement system entirely, as it remains an indispensable part of the immune system’s ability to combat infections. "The idea is not to remove complement systems that are required for us to fight infections," Dr. Dixit clarified. "Instead, the goal is to restore the balance." This nuanced approach highlights a focus on optimizing immune function rather than broadly suppressing it.

The implications of this research are far-reaching. By identifying a specific molecular target—C3—and demonstrating its link to both calorie restriction benefits and age-related inflammation, the study opens new avenues for therapeutic interventions. If existing drugs can be repurposed to modulate C3 activity, it could lead to novel strategies for promoting healthier aging, potentially reducing the burden of age-associated diseases and improving the quality of life for an aging global population. The ongoing research into targeting C3 represents a significant step forward in our understanding of the complex biological processes that govern aging and the development of interventions that can promote longevity with enhanced health.